What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.
We are a vibrant company full of hope, possibilities, and a belief that, working together as One Editas, we can truly revolutionize the development of medicines. We are on an important journey to unlock the full potential of genome editing technology. A journey fueled by our distinct culture, expert team of Editas Medicine ‘Editors’, and the patients we aspire to help around the world. Connect with us to hear about the tremendous progress and scientific advancements we’ve already made and the next breakthrough on the horizon. If you are ingenious, passionate and resilient, come join the revolution. Repairing broken genes is only the beginning.
Company Details
- Employees
- 232
- Founded
- -
- Address
- 11 Hurley St, Cambridge,massachusetts 02141,united States
- Phone
- (617) 401-9000
- in****@****med.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.editasmedicine.com
- Keywords
- Genome Editing, In Vivo (in body) Editing, Engineered Cell Medicines, Ocular Medicines, Genetic Diseases, Blood Diseases, Sickle Cell Disease, Cancer, Rare Diseases, Immunogenetics, Transfusion-Dependent Beta Thalassemia, Hematopoietic Stem Cells.
- HQ
- Cambridge, Massachusetts
Editas Medicine Questions
Editas Medicine's helpline number is (617) 401-9000
Editas Medicine's website is http://www.editasmedicine.com
Editas Medicine's LinkedIn profile is https://www.linkedin.com/company/editas-medicine
Editas Medicine has
232 employees.
View email and phone details for 232
employees at Editas Medicine.
Editas Medicine's industry is
Biotechnology Research
Editas Medicine's top competitors are
Sarepta Therapeutics,
Beam Therapeutics,
Intellia Therapeutics, Inc.,
Alnylam Pharmaceuticals,
Vertex Pharmaceuticals,
Tessera Therapeutics,
Crispr Therapeutics,
Bluebird Bio,
Agios Pharmaceuticals,
Verve Therapeutics.
Editas Medicine's support email address is info@editasmed.com
Editas Medicine's categories are Biotechnology Research
Editas Medicine's founding year is 2013
